COMMUNIQUÉS West-GlobeNewswire

Clearside Biomedical to Participate in 2018 Wedbush PacGrow Healthcare Conference

09/08/2018 - 14:00

ALPHARETTA, Ga., Aug. 09, 2018 (GLOBE NEWSWIRE) -- Clearside Biomedical, Inc. (NASDAQ:CLSD), a biopharmaceutical company dedicated to developing treatments that restore and preserve vision for people with serious eye [...]

Fibrocell Reports Second Quarter 2018 Financial Results and Recent Highlights

09/08/2018 - 14:00

Company to Host Conference Call and Webcast Today at 8:30 a.m. EDT EXTON, Pa., Aug. 09, 2018 (GLOBE NEWSWIRE) -- Fibrocell Science, Inc. (NASDAQ: FCSC), a gene therapy company focused on transformational autologous cell [...]

resTORbio Reports Second Quarter 2018 Financial Results

09/08/2018 - 14:00

Phase 2b results identify dose and patient population for pivotal program with RTB101 Initiation of pivotal program with RTB101 expected in the first half of 2019 BOSTON, Aug. 09, 2018 (GLOBE NEWSWIRE) -- resTORbio, Inc [...]

Progressive Care Announces Pay-Off of Note to Chicago Venture Partners

09/08/2018 - 14:00

MIAMI, Aug. 09, 2018 (GLOBE NEWSWIRE) -- Progressive Care Inc. (OTCQB: RXMD), a personalized healthcare services and technology company, today announced that it has paid off its convertible note to Chicago Venture [...]

Mustang Bio to Present at 10th Annual Bioprocessing Summit

09/08/2018 - 14:00

NEW YORK, Aug. 09, 2018 (GLOBE NEWSWIRE) -- Mustang Bio, Inc. (“Mustang”) (NASDAQ: MBIO), a Fortress Biotech (NASDAQ: FBIO) Company focused on the development of novel immunotherapies based on proprietary chimeric [...]

HTG Molecular Announces Amendment to Second Statement of Work with QIAGEN Manchester Limited

09/08/2018 - 14:00

TUCSON, Ariz., Aug. 09, 2018 (GLOBE NEWSWIRE) -- HTG Molecular Diagnostics, Inc. (Nasdaq: HTGM) (HTG), a provider of instruments, reagents, and services for molecular profiling applications, today announced that it has [...]

Aeglea BioTherapeutics Provides Corporate Update and Reports Second Quarter 2018 Financial Results

09/08/2018 - 14:00

AUSTIN, Texas, Aug. 09, 2018 (GLOBE NEWSWIRE) -- Aeglea BioTherapeutics, Inc. (NASDAQ:AGLE), a clinical-stage biotechnology company that designs and develops innovative human enzyme therapeutics for patients with rare [...]

Wave Life Sciences Reports Second Quarter 2018 Financial Results and Provides Business Update

09/08/2018 - 14:00

CAMBRIDGE, Mass., Aug. 09, 2018 (GLOBE NEWSWIRE) -- Wave Life Sciences Ltd. (NASDAQ: WVE), a biotechnology company focused on delivering transformational therapies for patients with serious, genetically-defined diseases [...]

Health Canada Gives Green Light to Tetra Bio-Pharma’s Cannabis Vs. Fentanyl Trial

09/08/2018 - 14:00

Patient recruitment to begin for landmark research ORLEANS, Ontario, Aug. 09, 2018 (GLOBE NEWSWIRE) -- Tetra Bio-Pharma Inc ., a leader in cannabinoid-based drug discovery and development (TSX VENTURE: TBP) (OTCQB: [...]

Portola Pharmaceuticals Appoints Ernie Meyer as Executive Vice President and Chief Human Resources Officer

09/08/2018 - 14:00

SOUTH SAN FRANCISCO, Calif., Aug. 09, 2018 (GLOBE NEWSWIRE) -- Portola Pharmaceuticals, Inc.® (Nasdaq:PTLA) today announced the appointment of Ernie Meyer as executive vice president and chief human resources officer, [...]

Krystal Biotech’s KB105 Granted Orphan Drug Designation by the FDA to Treat Patients With TGM-1 Deficient Autosomal Recessive Congenital Ichthyosis

09/08/2018 - 14:00

PITTSBURGH, Aug. 09, 2018 (GLOBE NEWSWIRE) -- Krystal Biotech , Inc. (Nasdaq:KRYS), a gene therapy company dedicated to developing and commercializing novel treatments for patients suffering from dermatological diseases [...]

Cocrystal Pharma Reports 2018 Second Quarter Financial Results and Provides Corporate Update

09/08/2018 - 14:00

– First half of 2018 marked by management’s successful execution of corporate, clinical and regulatory strategies – – Topline results from Phase 2a study evaluating CC-31244 for ultra-short treatment of HCV expected in [...]

Precipio Appoints New Board Member to Replace Departing Director

09/08/2018 - 13:37

Kathy LaPorte brings 30-year track record of VC success financing and operating innovative biopharma, diagnostics and healthcare companies NEW HAVEN, Conn., Aug. 09, 2018 (GLOBE NEWSWIRE) -- Specialty cancer diagnostics [...]

Moleculin Seeks Approval from Polish Regulatory Agency for Skin Cancer Clinical Trial

09/08/2018 - 13:30

HOUSTON, Aug. 09, 2018 (GLOBE NEWSWIRE) -- Moleculin Biotech, Inc., (Nasdaq: MBRX) ("Moleculin" or the "Company"), a clinical stage pharmaceutical company focused on the development of oncology drug candidates, all of [...]

IMV Inc. Reaches Multiple Milestones in Advanced Ovarian Cancer Clinical Trial

09/08/2018 - 13:05

HALIFAX, Nova Scotia, Aug. 09, 2018 (GLOBE NEWSWIRE) -- Enrollment Completed for Phase 1b Cohorts First Dosing Occurred in Phase 2 Portion of the Program IMV Inc. (Nasdaq: IMV; TSX: IMV), a clinical stage immuno- [...]

XOMA to Present at the 2018 Wedbush PacGrow Healthcare Conference and the 2018 Southern California Investor Conference

09/08/2018 - 13:00

EMERYVILLE, Calif., Aug. 09, 2018 (GLOBE NEWSWIRE) -- XOMA Corporation (NASDAQ: XOMA), a pioneer in the discovery, development and licensing of therapeutic antibodies, announced today its Chief Executive Officer, Jim [...]

Surgery Partners, Inc. Announces Second Quarter 2018 Results

09/08/2018 - 13:00

Strategic Initiatives Begin to Yield Near-Term Results, Position the Company for Significant Growth in 2019 and Beyond BRENTWOOD, Tenn., Aug. 09, 2018 (GLOBE NEWSWIRE) -- Surgery Partners, Inc. (NASDAQ:SGRY) ("Surgery [...]

R1 RCM Reports Second Quarter 2018 Results

09/08/2018 - 13:00

CHICAGO, Aug. 09, 2018 (GLOBE NEWSWIRE) -- R1 RCM Inc. (NASDAQ:RCM), a leading provider of technology-enabled revenue cycle management services to healthcare providers, today announced results for the three months ended [...]

Anavex Life Sciences Reports Fiscal Third Quarter 2018 Financial Results

09/08/2018 - 13:00

Conference Call and Webcast Today at 4:30 p.m. ET NEW YORK, Aug. 09, 2018 (GLOBE NEWSWIRE) -- Anavex Life Sciences Corp. (“Anavex” or the “Company”) (Nasdaq:AVXL), a clinical-stage biopharmaceutical company developing [...]